Search - tctmd.com

Displaying 61 - 80 of 279

Sort: Relevancy | Date

Presentation TCT 2018

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Presenter: Deepak L. Bhatt, Tullio Palmerini, Michael Maeng

September 23, 2018

Presentation TCT 2018

Ultra-Short DAPT (1 3 Months): For Which Patients and Stents Do We Have Evidence?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Philip M. Urban

September 23, 2018

Presentation TCT 2018

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Usman Baber

September 23, 2018

Presentation TCT 2018

Who Is the High Bleeding Risk Patient, and How Should DAPT Duration Be Weighed Against Ischemic Risk?

Presenter: Deepak L. Bhatt, Tullio Palmerini, Roxana Mehran

September 23, 2018

Presentation TCT 2018

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

Presenter: Fernando Alfonso, Juan F. Granada, Bruno Scheller

September 23, 2018

Presentation TCT 2018

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

Presenter: Fernando Alfonso, Juan F. Granada, Runlin Gao

September 23, 2018

Presentation TCT 2018

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

Presenter: Fernando Alfonso, Juan F. Granada, YunDai Chen

September 23, 2018

Presentation TCT 2018

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

Presenter: Fernando Alfonso, Juan F. Granada, David E. Kandzari

September 23, 2018

Presentation TCT 2018

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

Presenter: Michael Haude, Robert-Jan van Geuns, Yaling Han

September 23, 2018

Presentation TCT 2018

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Bo Xu

September 23, 2018

Presentation TCT 2018

BIOSOLVE-IV: Twelve-Month Outcomes With a Resorbable Magnesium Scaffold in a Real-world Setting

Presenter: Michael Haude, Robert-Jan van Geuns, Michael Kang-Yin Lee

September 23, 2018

Presentation TCT 2018

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Presenter: Michael Haude, Robert-Jan van Geuns, Antonio Colombo

September 23, 2018

Presentation TCT 2018

Flash Debate: Metallic BRS Have the Edge!

Presenter: Ron Waksman

September 22, 2018

Presentation TCT 2018

Flash Debate: Polymeric BRS Have the Edge!

Presenter: Pieter C. Smits

September 22, 2018

Presentation TCT 2018

ReCre8: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Pieter R. Stella

September 22, 2018

Presentation TCT 2018

Imaging and Clinical Results With the Latest Magmaris Magnesium-Based Scaffold

Presenter: Alexandre Abizaid, Ron Waksman, Michael Haude

September 22, 2018

News Conference News TCT 2018

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

Todd Neale

September 22, 2018

Presentation TCT 2018

TALENT: Summary and Clinical Implications

Presenter: Sripal Bangalore, Lawrence A. Garcia, Patrick W. Serruys

September 22, 2018

Presentation TCT 2018

Emerging Polymeric and Metallic BRS from China

Presenter: Alexandre Abizaid, Ron Waksman, Yaling Han

September 22, 2018

Presentation TCT 2018

Latest Results and Future Directions With the DESolve NXT PLLA-Based BRS With Contoured Struts

Presenter: Alexandre Abizaid, Ron Waksman

September 22, 2018

Advertisement

COMPASS Trial Revisited: Weighing Rivaroxaban Secondary Prevention vs DAPT After PCI

Ultra-Short DAPT (1 3 Months): For Which Patients and Stents Do We Have Evidence?

Patient Selection for Prolonged DAPT: Risk Scores or Wise Clinical Judgement?

Who Is the High Bleeding Risk Patient, and How Should DAPT Duration Be Weighed Against Ischemic Risk?

PEPCAD NSTEMI: A Randomized Trial Evaluating a Drug-Coated Balloon in Patients With Non-ST-Segment Elevation Myocardial Infarction

RESTORE SVD China: Randomized Trial of Drug-Coated Balloons vs Drug-Eluting Stents for Treatment of Small Vessel Disease

RESTORE ISR China: A Randomized Trial of Two Different Drug-Coated Balloons for Treatment of In-Stent Restenosis After Drug-Eluting Stent Implantation

BIOFLOW V: Two-Year Results of a Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent

I-LOVE-IT 2: Five-Year Results From a Randomized Trial of Biodegradable Polymer-Based and Durable Polymer-Based Drug-Eluting Stents

NEOVAS: Three-Year OCT and FFR Results From a Randomized Trial Evaluating a Polymeric Bioresorbable Scaffold

BIOSOLVE-IV: Twelve-Month Outcomes With a Resorbable Magnesium Scaffold in a Real-world Setting

RENASCENT III: Nine-Month Clinical and Imaging Outcomes With a Thin-Strut (98 micrometer) Bioresorbable Coronary Scaffold

Flash Debate: Metallic BRS Have the Edge!

Flash Debate: Polymeric BRS Have the Edge!

ReCre8: Summary and Clinical Implications

Imaging and Clinical Results With the Latest Magmaris Magnesium-Based Scaffold

TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers

TALENT: Summary and Clinical Implications

Emerging Polymeric and Metallic BRS from China

Latest Results and Future Directions With the DESolve NXT PLLA-Based BRS With Contoured Struts

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content